Contribution of studies on renal effects of heavy metals and selected organic compounds to our understanding of the progression of chronic nephropathies towards renal failure

Acta Biomedica de l'Ateneo Parmense

Volumn 76, Issue SUPPL. 2, 2005, Pages 58-67

  Franchini, Innocente ^a   Alinovi, Rossella ^a   Bergamaschi, Enrico ^a   Mutti, Antonio ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Kidney; Lead; Microalbuminuria; Microproteinuria; Organic solvents

Indexed keywords

BIOLOGICAL MARKER; CADMIUM; CHROMIUM; HEAVY METAL; HYDROCARBON; INDUSTRIAL CHEMICAL; LEAD; MERCURY; ORGANIC COMPOUND; ORGANIC SOLVENT; VOLATILE AGENT;

CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; DISEASE COURSE; DISEASE MARKER; DNA ADDUCT; GLOMERULUS FILTRATION; HUMAN; KIDNEY FAILURE; LEAD POISONING; MERCURIALISM; MICROALBUMINURIA; MICROPROTEINURIA; NEPHROTOXICITY; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; OCCUPATIONAL MEDICINE; PRIMARY PREVENTION; PROTEINURIA; RISK ASSESSMENT; RISK FACTOR; WORKPLACE;

ANIMALS; BIOLOGICAL MARKERS; CHRONIC DISEASE; DISEASE PROGRESSION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; METALS, HEAVY; OCCUPATIONAL DISEASES; RISK FACTORS;

EID: 31944442214     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (63)

1. IPCS-UNEP-ILO-WHO. Principles and methods for the assessment of nephrotoxicity associated with exposure to chemicals. Environmental Health Criteria series, n. 119, World Health Organization, Geneva, 1991.
2. Mutti A. Detection of renal diseases in humans: developing markers and methods. Toxicol Lett 1989; 46(1-3): 177-91.
3. Berthoux F, Jones E, Gellert R, Mendel S, Saker L, Briggs D. Epidemiological data of treated end-stage renal failure in the European Union (EU) during the year 1995: report of the European Renal Association Registry and the National Registries. Nephrol Dial Transplant 1999; 14: 2332-23.
4. Dieperink HH. Identification of groups at risk for renal diseases (including nephrotoxicity). Toxicol Lett 1989; 46: 257-68.
5. Bernard A, Lauwerys RR. Effects of cadmium exposure in man. In: Foulkes, E.C., ed. Cadmium toxicology. Handbook of Experimental Pharmacology, Berlin, Heidelberg, New York, Springer-Verlag, 1986, Vol. 80, 136-77.
6. Roels H, Lauwerys RR, Buchet JP, Bernard A, Vos A, Oversteyns M. A prospective study of proteinuria in cadmium workers. In: Bach, P.H. & Lock, E.A., ed. Nephrotoxicity: Extrapolation from in vitro to in vivo, and animals to man, New York, London, Plenum Press, 1989, 33-6.
7. Nuyts GD, Van Vlem E, Thys J, et al. New occupational risk factors for chronic renal failure. Lancet 1995; 346(8966): 7-11.
8. UNEP-ILO-WHO. Biomarkers in risk assessment: validity and validation. Appendix II. Biomarkers of exposure and effect for non carcinogenic end-points. Environmental Health Criteria, n. 222, World Health Organization, Geneva, 2001.
9. Goyer R, Eknoyan G, De Broe ME, et al. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins: II. Nephrotoxins of significant frequency and economic impact. Ren Fail 1997; 19(4): 523-34.
10. NRC (National Research Council). Biological markers in environmental health research. Environ Health Perspect 1987; 74: 3-9.
11. Price RG. Urinalysis to exclude and monitor nephrotoxicity. Clin Chim Acta 2000, 297(1-2): 173-82.
12. Mutti A. Use of intermediate end-points to prevent long-term outcomes. ToxicolLett 1995, 77: 121-5.
13. Friberg L. Health hazards in the manufacture of alkaline accumulators with special reference to chronic cadmium poisoning. Acta Med Scand 1950, Suppl. 240.
14. Piscator M. Proteinuria in chronic cadmium poisoning. I. An electrophoretic and chemical study of urinary and serum proteins from workers with chronic cadmium poisoning. Arch Environ Health 1962, 4: 607-21.
15. Piscator M. Proteinuria in chronic cadmium poisoning. III. Electrophoretic and immunoelectrophoretic studies on urinary proteins from cadmium workers, with special reference to the excretion of low molecular weight proteins. Arch Environ Health 1966; 335-44.
16. Piscator M. Proteinuria in chronic cadmium poisoning. IV. Gel-filtration and ion-exchange chromatography of urinary proteins from cadmium workers. Arch Environ Health 1966; 4: 607-21.
17. Bernard A, Buchet JP, Roels H, Masson P, Lauwerys R. Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest 1979; 9: 11-22.
18. Mutti A, Lucertini S, Valcavi PP, et al. Urinary excretion of brush-border antigen revealed by a monoclonal antibody: early indicator of toxic nephropathy. Lancet 1985; 2 (8461): 914-7.
19. Mutti A, Alinovi R, Bergamaschi E, et al. Monoclonal antibodies to brush border antigens for the early diagnosis of nephrotoxicity. Arch Toxicol 1988; suppl. 12: 162-5.
20. Price RG, Berndt WO, Finn WF, et al. Urinary biomarkers to detect significant effects of environmental and occupational exposure to nephrotoxins. III. Minimal battery of tests to assess subclinical nephrotoxicity for epidemiological studies based on current knowledge. Ren Fail 1997; 19(4): 535-52.
21. Mutti A, Alinovi R, Bergamaschi E, Franchini I. Reference values for early markers of renal damage. Sci Total Environ 1992; 120(1-2): 7-15.
22. Bergamaschi E, Mutti A, Alinovi R, et al. Tubular reabsorption of proteins is a selective process. Contrib Nephrol 1993; 101: 92-8.
23. Franchini I, Mutti A, Cavatorta A, et al. Nephrotoxicity of chromium. Remarks on an experimental and epidemiological investigation. Contrib Nephrol 1978; 10: 98-110.
24. Franchini I, Mutti A. Selected toxicological aspects of chromium(VI) compounds. Sci Total Environ 1988; 71(3): 379-87.
25. Nuyts GD, Roels HA, Verpooten GF, Bernard AM, Lauwerys RR, De Broe ME. Intestinal-type alkaline phosphatase in urine as an indicator of mercury-induced effects on the S3 segment of the proximal tubule. Nephrol Dial Transoplant 1992; 7: 225-9.
26. Cardenas A, Roels H, Bernard AM, et al. Markers of early renal changes induced by industrial pollutants. I Application to workers exposed to mercury vapour. Br J Ind Med 1993; 50(1): 17-27.
27. Alinovi R, Buzio L, Mozzoni P, et al. Effetti renali di basse dosi di mercurio. Med Lav 2002; 93(3): 191-201.
28. Goldman M, Baran D, Druet P. Polyclonal activation and experimental nephropathies. Kidney Int 1988; 34: 141-50.
29. Hua J, Pelletier L, Berlin M, Druet P. Autoimmune glomerulonephritis induced by mercury vapour exposure in the Brown Norway rat. Toxicology 1993; 79: 119-29.
30. Weening JJ, Fleuren GJ, Hoedemaeker PJ. Demonstration of antinuclear antibodies in mercuric chloride-induced glomerulopathy in the rat. Lab Invest 1978; 39: 405-11.
31. Cardenas A, Roels H, Bernard AM, et al. Markers of early renal changes induced by industrial pollutants. II Application to workers exposed to lead. Br J Ind Med 1993; 50(1): 28-36.
32. Weeden RP. Lead and renal disease. Lancet. 1978; 2: 477.
33. Kopp SJ, Barron JT, Tow JP. Cardiovascular actions of lead and relationship to hypertension: a review. Scand J Work Environ Health 1985; 11: 15-20.
34. Fels LM, Herbort C, Pergande M, et al. Nephron target sites in chronic exposure to lead. Nephrol Dial Transplant 1994; 9: 1740-6.
35. Khalil-Manesh F, Gonick HC, Cohen AH, et al. Experimental model of lead nephropathy. I. Continuous high-dose lead administration. Kidney Int 1992; 41(5): 1192-203.
36. Roels H, Lauwerys R, Konings J, et al. Renal function and hyperfiltration capacity in lead smelter workers with high bone lead. Occup Environ Med 1994; 51(8): 505-12.
37. Goyer RA, Weinberg CR, Victery WM, Miller CR. Lead induced nephrotoxicity: kidney calcium as an indicator of tubular injury. In: PH Bach and EA Lock (Eds): Nephrotoxicity. In Vitro to In Vivo, Animals to Man. Plenum Press, New York and London, 1989, 11-20
38. Chia KS, Mutti A, Alinovi R, et al. Urinary excretion of tubular brush-border antigens among lead exposed workers. Ann Acad Med Singapore 1994; 23: 655-9.
39. Chia KS, Mutti A, Tan C, et al. Urinary N-acetyl-beta-D-glucosaminidase activity in workers exposed to inorganic lead. Occup Environ Med 1994; 51(2): 125-9.
40. Friberg L, Blinder CG, Kjellström T, Nordberg GF. Camium and health: a toxicological and epidemiological appraisal; vol 2. Boca Raton (FL): CRC Press, 1986.
41. Roels H, Bernard AM, Cardenas A, et al. Markers of early renal changes induced by industrial pollutants. III. Application to workers exposed to cadmium. Br J Ind Med 1993; 50(1): 37-48.
42. Bernard A. Renal dysfunction induced by cadmium: biomarkers of critical effects. Biometals 2004; 17: 519-23.
43. Järup L, Berglund M, Blinder CG, Nordberg G, Vahter M. Health effects of cadmium exposure - a review of the literature and a risk estimate. Scand J Work Environ Health 1998; 24(S1): 1-52.
44. Järup L. Cadmium overload and toxicity. Nephrol Dial Transplant 2002; 17: 35-9.
45. Bernard A, Thielemans N, Roels H, Lauwerys R. Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 1995; 52: 177-80.
46. Roels HA, Van Assche FJ, Oversteyns M, deGroof M, Lauwerys RR, Lison D. Reversibility of microproteinuria in cadmium workers with incipient tubular dysfunction after reduction of exposure. Am J Ind Med 1997; 31: 645-52.
47. Roels HA, Lauwerys RR, Buchet JP, Bernard AM, Vos A, Oversteyns M. Health significance of cadmium induced renal dysfunction: a five year follow-up. Br J Ind Med 1989; 46: 755-64.
48. Mutti A. Organic solvents and the kidney. J Occup Health 1996; 38: 162-9.
49. Zimmerman SW, Groheler K, Beirne GJ. Hydrocarbon exposure and chronic glomerulonephritis. Lancet 1975; 2 (7927): 199-201.
50. Ravnskov U, Lundstrom S, Norden A. Hydrocarbon exposure and glomerulonephritis: evidence from patient's occupations. Lancet 1983; 2: 1214-6
51. Yaqoob M, Bell GM, Percy DF, Finn R. Primary glomerulonephritis and hydrocarbon exposure: a case-control study and literature review. Q J Med 1992, New Series 83; 301: 409-18.
52. Mutti A, Lucertini S, Falzoi M, Cavatorta A, Franchini I. Organic solvents and chronic glomerulonephritis: a cross-sectional study with negative findings for aliphatic and alicyclic C5-C7 hydrocarbons. J Appl Toxicol 1981; 1: 224-6.
53. Bergamaschi E, Mutti A, Bocchi MC, et al. Rat model of perchloroethylene-induced renal dysfunctions. Env Res 1992; 59: 427-39.
54. Franchini I, Cavatorta A, Falzoi M, Lucertini S, Mutti A. Early indicators of renal damage in workers exposed to organic solvents. Int Arch Occup Environ Health 1983; 52: 1-9.
55. Viau C, Bernard A, Lauwerys R, et al. A cross-sectional survey of kidney function in refinery workers. Am J Ind Med 1987; 11: 177-87.
56. Mutti A, Alinovi R, Bergamaschi E, et al. Nephropathies and exposure to perchloroethylene in dry-cleaners. Lancet 1992; 340: 189-93.
57. Stengel B, Cenee S, Limasset JC, et al. Organic solvent exposure may increase the risk of glomerular nephropathies with chronic renal failure. Int J Epidemiol 1995; 24(2): 427-34.
58. Yaqoob M, Stevenson A, Mason H, Bell GM. Hydrocarbon exposure and tubular damage: additional factors in the progression of renal failure in primary glomerulonephritis. Q J Med 1993; 86(10): 661-7.
59. Mutti A, Coccini T, Alinovi R, et al. Exposure to hydrocarbons and renal disease: an experimental animal model. Renal Failure 1999; 21(3-4): 369-85.
60. Ginevri F, Mutti A, Fabbretti G, et al. Proteinuria and progression of chronic adriamycin nephropathy. Contrib Nephrol 1993; 101: 220-6.
61. Mutti A, Alinovi R, Ghiggeri GM, et al. Urinary excretion of brush-border antigen and plasma proteins in early stages of diabetic nephropathy. Clin Chim Acta 1990; 30: 93-100.
62. Abbate M, Zoja C, Corna D, Capitanio M, Bertani T, Remuzzi G. In progressive nephropathies, overload of tubular cells with filtered proteins translates glomerular permeability dysfunction into cellular signals of interstitial inflammation. J Am Soc Nephrol 1998; 9: 1213-24.
63. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-56.